Vista Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company has its United States Food and Drug Administration (USFDA) approved manufacturing facility in India and its marketing and distribution center in United States. Its products include tablet dosage forms and capsule dosage forms. The Company's tablet dosage forms in United States market include sulfamethoxazole & trimethoprim (400/80 mg) and acetaminophen (500 mg) film coated. The Company's tablet dosage forms in Non-United States market include aspirin (300, 325 & 500 mg), atenolol (50 & 100 mg), cotrimoxazole (480 mg), captopril (25 & 50 mg) and frusemide (40 mg). Its capsule dosage forms in Non-United States market include indomethacin (25 mg), piroxicam (10 & 20 mg) and nifedipine (10 mg).As of 26 May 2026, VISTA PHARMACEUTICALS LTD. share price is ₹7.28. The stock opened at ₹7.30, compared to its previous close of ₹7.32. During today's trading session, VISTA PHARMACEUTICALS LTD. share price moved in the range of ₹6.90 to ₹7.32, with an average price of ₹7.11 for the day. Looking at its last 52-week, the stock has touched a low of ₹6.90 and a high of ₹7.32.
The market capitalization of VISTA PHARMACEUTICALS LTD. is ₹45 Crs, with a P/E ratio of -5.9 and a dividend yield of 0.00%.